JP2009537546A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009537546A5 JP2009537546A5 JP2009511069A JP2009511069A JP2009537546A5 JP 2009537546 A5 JP2009537546 A5 JP 2009537546A5 JP 2009511069 A JP2009511069 A JP 2009511069A JP 2009511069 A JP2009511069 A JP 2009511069A JP 2009537546 A5 JP2009537546 A5 JP 2009537546A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- optionally substituted
- independently
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 hydroxy, carboxy Chemical group 0.000 claims description 255
- 150000001875 compounds Chemical class 0.000 claims description 182
- 125000000217 alkyl group Chemical group 0.000 claims description 85
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 53
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 46
- 229910052799 carbon Inorganic materials 0.000 claims description 44
- 229910052739 hydrogen Inorganic materials 0.000 claims description 44
- 150000003839 salts Chemical class 0.000 claims description 44
- 125000005843 halogen group Chemical group 0.000 claims description 32
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 28
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 26
- 125000004076 pyridyl group Chemical group 0.000 claims description 22
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 22
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 19
- 125000001153 fluoro group Chemical group F* 0.000 claims description 18
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000000651 prodrug Substances 0.000 claims description 13
- 229940002612 prodrug Drugs 0.000 claims description 13
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 12
- 208000030507 AIDS Diseases 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- 125000002947 alkylene group Chemical group 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 229940124597 therapeutic agent Drugs 0.000 claims description 8
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 7
- KOAMXHRRVFDWRQ-UHFFFAOYSA-N 4,4-dimethyl-5h-1,3-oxazole Chemical compound CC1(C)COC=N1 KOAMXHRRVFDWRQ-UHFFFAOYSA-N 0.000 claims description 6
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 6
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 6
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 6
- 239000002955 immunomodulating agent Substances 0.000 claims description 5
- 230000002584 immunomodulator Effects 0.000 claims description 5
- 229940121354 immunomodulator Drugs 0.000 claims description 5
- 125000005960 1,4-diazepanyl group Chemical group 0.000 claims description 4
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 4
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims description 4
- 125000000984 3-chloro-4-fluorobenzyl group Chemical group [H]C1=C(F)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 claims description 4
- 229910020366 ClO 4 Inorganic materials 0.000 claims description 4
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 229960005475 antiinfective agent Drugs 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 4
- 125000006239 protecting group Chemical group 0.000 claims description 4
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims description 4
- 125000003107 substituted aryl group Chemical group 0.000 claims description 4
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 125000001072 heteroaryl group Chemical group 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 claims description 2
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 claims description 2
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 claims description 2
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims description 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- 201000008686 ARC syndrome Diseases 0.000 claims description 2
- 208000003685 Arthrogryposis-renal dysfunction-cholestasis syndrome Diseases 0.000 claims description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 2
- 108010002459 HIV Integrase Proteins 0.000 claims description 2
- 229940122440 HIV protease inhibitor Drugs 0.000 claims description 2
- 102100034343 Integrase Human genes 0.000 claims description 2
- 108010061833 Integrases Proteins 0.000 claims description 2
- 150000001204 N-oxides Chemical class 0.000 claims description 2
- 229940122313 Nucleoside reverse transcriptase inhibitor Drugs 0.000 claims description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 2
- 230000000840 anti-viral effect Effects 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000035475 disorder Diseases 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 2
- 239000004030 hiv protease inhibitor Substances 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 2
- 229940042402 non-nucleoside reverse transcriptase inhibitor Drugs 0.000 claims description 2
- 239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 claims description 2
- 239000006186 oral dosage form Substances 0.000 claims description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000004193 piperazinyl group Chemical group 0.000 claims description 2
- 125000003386 piperidinyl group Chemical group 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims description 2
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 10
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 9
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 claims 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 2
- 125000006738 (C6-C20) heteroaryl group Chemical group 0.000 claims 1
- ABEZSNUKWWRRLT-UHFFFAOYSA-N 2-(2,5-dimethylpyrrolidin-1-yl)pyridine Chemical compound CC1CCC(C)N1C1=CC=CC=N1 ABEZSNUKWWRRLT-UHFFFAOYSA-N 0.000 claims 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 239000000677 immunologic agent Substances 0.000 claims 1
- 229940124541 immunological agent Drugs 0.000 claims 1
- 239000012678 infectious agent Substances 0.000 claims 1
- 150000003457 sulfones Chemical class 0.000 claims 1
- 0 CN(C1C(CN(*)C2=O)=C2C(O)=C(*)[C@]1*=C(*)C(*)=C)S(*1CC1)(=O)=O Chemical compound CN(C1C(CN(*)C2=O)=C2C(O)=C(*)[C@]1*=C(*)C(*)=C)S(*1CC1)(=O)=O 0.000 description 29
- 125000003545 alkoxy group Chemical group 0.000 description 15
- 125000003342 alkenyl group Chemical group 0.000 description 10
- 125000000304 alkynyl group Chemical group 0.000 description 10
- KRLUPQZMBMYKDO-UHFFFAOYSA-N CCN(Cc(c1c(c2c3cc(Cc(cc4)ccc4F)cn2)O)c3N(C)S(C)(O)O)C1=O Chemical compound CCN(Cc(c1c(c2c3cc(Cc(cc4)ccc4F)cn2)O)c3N(C)S(C)(O)O)C1=O KRLUPQZMBMYKDO-UHFFFAOYSA-N 0.000 description 5
- FKSCUHWQDYJVAP-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CN(Cc(cc1)ccc1O)C1=O)c1c2O)S(C)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CN(Cc(cc1)ccc1O)C1=O)c1c2O)S(C)(=O)=O FKSCUHWQDYJVAP-UHFFFAOYSA-N 0.000 description 5
- JEQWHEUJDGAWNT-UHFFFAOYSA-N CNc(c1cc(Cc(cc2)ccc2F)cnc11)c(CN(CCF)C2=O)c2c1O Chemical compound CNc(c1cc(Cc(cc2)ccc2F)cnc11)c(CN(CCF)C2=O)c2c1O JEQWHEUJDGAWNT-UHFFFAOYSA-N 0.000 description 5
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 4
- MSZBWXNNSBLUGG-UHFFFAOYSA-N CC(c(cc1)ccc1F)N(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)C1=O Chemical compound CC(c(cc1)ccc1F)N(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)C1=O MSZBWXNNSBLUGG-UHFFFAOYSA-N 0.000 description 4
- FGAIXFHTMHMTBQ-UHFFFAOYSA-N CCCN(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)C1=O Chemical compound CCCN(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)C1=O FGAIXFHTMHMTBQ-UHFFFAOYSA-N 0.000 description 4
- NAHDJFBYFPNOBI-UHFFFAOYSA-N CCN(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)C1=O Chemical compound CCN(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)C1=O NAHDJFBYFPNOBI-UHFFFAOYSA-N 0.000 description 4
- YEVGAMNAGQNEAD-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CN(Cc1ccc[s]1)C1=O)c1c2O)S(C)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CN(Cc1ccc[s]1)C1=O)c1c2O)S(C)(=O)=O YEVGAMNAGQNEAD-UHFFFAOYSA-N 0.000 description 4
- BSIUOMBOECIOTA-UHFFFAOYSA-N CN(c(c1cccnc11)c(CN(Cc(cc(cc2)Cl)c2O)C2=O)c2c1O)S(C)(=O)=O Chemical compound CN(c(c1cccnc11)c(CN(Cc(cc(cc2)Cl)c2O)C2=O)c2c1O)S(C)(=O)=O BSIUOMBOECIOTA-UHFFFAOYSA-N 0.000 description 4
- QMXPMYKXLRRXLH-UHFFFAOYSA-N COc(c(CN1Cc(cc2)ccc2F)c2C1=O)c(cc(Cc(cc1)ccc1F)cn1)c1c2O Chemical compound COc(c(CN1Cc(cc2)ccc2F)c2C1=O)c(cc(Cc(cc1)ccc1F)cn1)c1c2O QMXPMYKXLRRXLH-UHFFFAOYSA-N 0.000 description 4
- YUDBTHOTDOVDPX-UHFFFAOYSA-N COc(c1c2cc(Cc(cc3)ccc3F)cn1)c(CNC1=O)c1c2O Chemical compound COc(c1c2cc(Cc(cc3)ccc3F)cn1)c(CNC1=O)c1c2O YUDBTHOTDOVDPX-UHFFFAOYSA-N 0.000 description 4
- YEFOXKSIHIQCSX-UHFFFAOYSA-N COc(c1c2ncc(Cc(cc3Cl)ccc3F)c1)c(CNC1=O)c1c2O Chemical compound COc(c1c2ncc(Cc(cc3Cl)ccc3F)c1)c(CNC1=O)c1c2O YEFOXKSIHIQCSX-UHFFFAOYSA-N 0.000 description 4
- SNOYKBQOQOUCKA-UHFFFAOYSA-N COc(c1cc(Cc(cc2)ccc2F)cnc11)c(CN(CC2CC2)C2=O)c2c1O Chemical compound COc(c1cc(Cc(cc2)ccc2F)cnc11)c(CN(CC2CC2)C2=O)c2c1O SNOYKBQOQOUCKA-UHFFFAOYSA-N 0.000 description 4
- MMINLSQHDGWSOD-JIIJFBHESA-N CC(/C=C(/CNCc(c(C=O)c(c1c2cccn1)O)c2N(C)S=O)\O)=N Chemical compound CC(/C=C(/CNCc(c(C=O)c(c1c2cccn1)O)c2N(C)S=O)\O)=N MMINLSQHDGWSOD-JIIJFBHESA-N 0.000 description 3
- KNYWQXUBQLSYEK-UHFFFAOYSA-N CC(C)(CCN(Cc(c1c(c2c3cc(Cc(cc4)ccc4F)cn2)O)c3N(C)[S-](C)(O)=O)C1=O)O Chemical compound CC(C)(CCN(Cc(c1c(c2c3cc(Cc(cc4)ccc4F)cn2)O)c3N(C)[S-](C)(O)=O)C1=O)O KNYWQXUBQLSYEK-UHFFFAOYSA-N 0.000 description 3
- HAEXYXPKRIQBGZ-UHFFFAOYSA-N CCN(CC)CCNCc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2NC Chemical compound CCN(CC)CCNCc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2NC HAEXYXPKRIQBGZ-UHFFFAOYSA-N 0.000 description 3
- JDORNULQMHWAAS-UHFFFAOYSA-O CCN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(C)c(C=O)c2O)[SH+](C)=O Chemical compound CCN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(C)c(C=O)c2O)[SH+](C)=O JDORNULQMHWAAS-UHFFFAOYSA-O 0.000 description 3
- LPZHLKWNUOWABH-UHFFFAOYSA-N CCNc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNC)c(C=O)c2O Chemical compound CCNc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNC)c(C=O)c2O LPZHLKWNUOWABH-UHFFFAOYSA-N 0.000 description 3
- SSVHHCKSYRYWLI-UHFFFAOYSA-O CCOCCNCCNCc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2N(C)[S+](C)O Chemical compound CCOCCNCCNCc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2N(C)[S+](C)O SSVHHCKSYRYWLI-UHFFFAOYSA-O 0.000 description 3
- UETKLDXUAFROKS-UHFFFAOYSA-N CN(c(c1c2[N-]CC=C1)c(CNCc(cc1)cc(C(F)(F)F)c1F)c(C=O)c2O)S(C)(=O)=O Chemical compound CN(c(c1c2[N-]CC=C1)c(CNCc(cc1)cc(C(F)(F)F)c1F)c(C=O)c2O)S(C)(=O)=O UETKLDXUAFROKS-UHFFFAOYSA-N 0.000 description 3
- MNWACLJYKBNMGE-UHFFFAOYSA-N CN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN)c(C=O)c2O)S(C)(=O)=O Chemical compound CN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN)c(C=O)c2O)S(C)(=O)=O MNWACLJYKBNMGE-UHFFFAOYSA-N 0.000 description 3
- KKESFMYGUCNPIQ-UHFFFAOYSA-O CN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNCCO)c(C=O)c2O)[SH+](C)(O)O Chemical compound CN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNCCO)c(C=O)c2O)[SH+](C)(O)O KKESFMYGUCNPIQ-UHFFFAOYSA-O 0.000 description 3
- URWXXGAQXZVQFV-UHFFFAOYSA-N CN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNCCOC)c(C=O)c2O)S(C)(O)=O Chemical compound CN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNCCOC)c(C=O)c2O)S(C)(O)=O URWXXGAQXZVQFV-UHFFFAOYSA-N 0.000 description 3
- WREOMGYDFNWWBD-UHFFFAOYSA-N CN(c(c1cccnc11)c(CNCC(C=C2)=CCN2OC)c(C=O)c1O)S(C)(=O)=O Chemical compound CN(c(c1cccnc11)c(CNCC(C=C2)=CCN2OC)c(C=O)c1O)S(C)(=O)=O WREOMGYDFNWWBD-UHFFFAOYSA-N 0.000 description 3
- PKSDOIYFPDYCDG-UHFFFAOYSA-N CNc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN(CCOC)C1=O)c1c2O Chemical compound CNc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN(CCOC)C1=O)c1c2O PKSDOIYFPDYCDG-UHFFFAOYSA-N 0.000 description 3
- WBNHBOHGJRCHNE-UHFFFAOYSA-N CNc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNCCF)c(C=O)c2O Chemical compound CNc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNCCF)c(C=O)c2O WBNHBOHGJRCHNE-UHFFFAOYSA-N 0.000 description 3
- LPQMJCFDAKAJQI-UHFFFAOYSA-N Cc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2NC Chemical compound Cc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2NC LPQMJCFDAKAJQI-UHFFFAOYSA-N 0.000 description 3
- YCEQDPKWYABHME-UHFFFAOYSA-N Cc(c(C[NH+](Cc(cccc1Cl)c1O)[O-])c(c1c2nccc1)N(C)S(C)(=O)=O)c2O Chemical compound Cc(c(C[NH+](Cc(cccc1Cl)c1O)[O-])c(c1c2nccc1)N(C)S(C)(=O)=O)c2O YCEQDPKWYABHME-UHFFFAOYSA-N 0.000 description 3
- SMRUPBPTWKFFSN-UHFFFAOYSA-N Cc1ccc(CNCc(c(C=O)c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)[o]1 Chemical compound Cc1ccc(CNCc(c(C=O)c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)[o]1 SMRUPBPTWKFFSN-UHFFFAOYSA-N 0.000 description 3
- 125000001589 carboacyl group Chemical group 0.000 description 3
- WBISWPYSKUPLHO-KAMUKELFSA-N C/C=C(/CNS(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O)\C=N Chemical compound C/C=C(/CNS(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O)\C=N WBISWPYSKUPLHO-KAMUKELFSA-N 0.000 description 2
- RWRQMEOUFKMRRU-UHFFFAOYSA-N C=[O]=C(c1cc(Cc(cc2)ccc2F)cnc11)OC1=O Chemical compound C=[O]=C(c1cc(Cc(cc2)ccc2F)cnc11)OC1=O RWRQMEOUFKMRRU-UHFFFAOYSA-N 0.000 description 2
- XVNPUXYPOLARER-XXOBPDLLSA-O CC(/C=C(/CNCc(c(C=O)c(c1c2cccn1)O)c2N(C)S(C)(=O)=O)\[OH2+])=N Chemical compound CC(/C=C(/CNCc(c(C=O)c(c1c2cccn1)O)c2N(C)S(C)(=O)=O)\[OH2+])=N XVNPUXYPOLARER-XXOBPDLLSA-O 0.000 description 2
- NTJFRNGERUJWET-UHFFFAOYSA-N CC(C(N(CCNC)C(C1C=C(Cc(cc2)ccc2F)C=NC11)=O)=C1O)=O Chemical compound CC(C(N(CCNC)C(C1C=C(Cc(cc2)ccc2F)C=NC11)=O)=C1O)=O NTJFRNGERUJWET-UHFFFAOYSA-N 0.000 description 2
- VQQQBAGYBUSYTD-UHFFFAOYSA-N CC(C)(CCNCc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2OC)O Chemical compound CC(C)(CCNCc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2OC)O VQQQBAGYBUSYTD-UHFFFAOYSA-N 0.000 description 2
- WORFQPAUFMPMAW-UHFFFAOYSA-N CC(C)NCNCCS(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O Chemical compound CC(C)NCNCCS(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O WORFQPAUFMPMAW-UHFFFAOYSA-N 0.000 description 2
- DYMKJALBMHDKNT-UHFFFAOYSA-N CC(C)OC(c1ncc(Cc(cc2)ccc2F)cc1C(O)=O)=O Chemical compound CC(C)OC(c1ncc(Cc(cc2)ccc2F)cc1C(O)=O)=O DYMKJALBMHDKNT-UHFFFAOYSA-N 0.000 description 2
- XROBRSFZDDSWDL-UHFFFAOYSA-N CC(NCCNCCS(N(C)c(c1c2nccc1)c(C[NH+](Cc(cc1)ccc1F)[O-])c(C)c2O)(=O)=O)=O Chemical compound CC(NCCNCCS(N(C)c(c1c2nccc1)c(C[NH+](Cc(cc1)ccc1F)[O-])c(C)c2O)(=O)=O)=O XROBRSFZDDSWDL-UHFFFAOYSA-N 0.000 description 2
- QIABZZPOMQUYFI-UHFFFAOYSA-N CC(Nc1cc(F)ccc1CN(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)C1=O)=O Chemical compound CC(Nc1cc(F)ccc1CN(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)C1=O)=O QIABZZPOMQUYFI-UHFFFAOYSA-N 0.000 description 2
- MPWBYVDDAZSDFK-UHFFFAOYSA-N CC(Nc1cc(F)ccc1CNCc1c(C=O)c(O)c2ncccc2c1N(C)S(C)(=O)=O)=O Chemical compound CC(Nc1cc(F)ccc1CNCc1c(C=O)c(O)c2ncccc2c1N(C)S(C)(=O)=O)=O MPWBYVDDAZSDFK-UHFFFAOYSA-N 0.000 description 2
- GMCRMNFQYGBTSJ-UHFFFAOYSA-N CC1N(CCN(c(c2c3nccc2)c(CN(Cc(cc2)ccc2F)C2=O)c2c3O)S(C)(=O)=O)C(C)CC1 Chemical compound CC1N(CCN(c(c2c3nccc2)c(CN(Cc(cc2)ccc2F)C2=O)c2c3O)S(C)(=O)=O)C(C)CC1 GMCRMNFQYGBTSJ-UHFFFAOYSA-N 0.000 description 2
- JFRWPZNKSPFOMA-UHFFFAOYSA-O CC=C(CN(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)C1=O)C=C[NH2+]OC Chemical compound CC=C(CN(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)C1=O)C=C[NH2+]OC JFRWPZNKSPFOMA-UHFFFAOYSA-O 0.000 description 2
- FSVJBLNYVCOBIU-UHFFFAOYSA-N CCN(C)S(N(C)c(c1c2nccc1)c(CN(CC1C=CC(F)=CC1)C1=O)c1c2O)(=O)=O Chemical compound CCN(C)S(N(C)c(c1c2nccc1)c(CN(CC1C=CC(F)=CC1)C1=O)c1c2O)(=O)=O FSVJBLNYVCOBIU-UHFFFAOYSA-N 0.000 description 2
- SHXWQGDWIIGNRK-UHFFFAOYSA-N CCN(CC)CCN(Cc(c1c(c2c3C=C(Cc(cc4)ccc4F)C[N-]2)O)c3NC)C1=O Chemical compound CCN(CC)CCN(Cc(c1c(c2c3C=C(Cc(cc4)ccc4F)C[N-]2)O)c3NC)C1=O SHXWQGDWIIGNRK-UHFFFAOYSA-N 0.000 description 2
- IQEZRSXDARHRSR-UHFFFAOYSA-N CCN(CC)S(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O Chemical compound CCN(CC)S(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O IQEZRSXDARHRSR-UHFFFAOYSA-N 0.000 description 2
- ZPWUJLKNPSAZBT-UHFFFAOYSA-N CCN(CNC)C(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)=O Chemical compound CCN(CNC)C(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)=O ZPWUJLKNPSAZBT-UHFFFAOYSA-N 0.000 description 2
- RXNPBTWNWZHPSO-UHFFFAOYSA-N CCN(Cc1c2c(O)c3ncc(Cc(cc4)ccc4F)cc3c1OC)C2=O Chemical compound CCN(Cc1c2c(O)c3ncc(Cc(cc4)ccc4F)cc3c1OC)C2=O RXNPBTWNWZHPSO-UHFFFAOYSA-N 0.000 description 2
- DNPMBWAGPODNEB-UHFFFAOYSA-N CCN(c(c1cc(Cc(cc2)ccc2F)cnc11)c(C)c(C=O)c1O)S(C)(=O)=O Chemical compound CCN(c(c1cc(Cc(cc2)ccc2F)cnc11)c(C)c(C=O)c1O)S(C)(=O)=O DNPMBWAGPODNEB-UHFFFAOYSA-N 0.000 description 2
- ZOZBWAYPCWLXOT-UHFFFAOYSA-N CCNCCS(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O Chemical compound CCNCCS(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O ZOZBWAYPCWLXOT-UHFFFAOYSA-N 0.000 description 2
- PHMFUYGYEMIUOM-UHFFFAOYSA-N CCNCc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2OC Chemical compound CCNCc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2OC PHMFUYGYEMIUOM-UHFFFAOYSA-N 0.000 description 2
- YNNVOQCBZUOIPW-UHFFFAOYSA-N CCOCNCCN(Cc(c1c(c2c3cc(Cc(cc4)ccc4F)cn2)O)c3N(C)S(C)(O)O)C1=O Chemical compound CCOCNCCN(Cc(c1c(c2c3cc(Cc(cc4)ccc4F)cn2)O)c3N(C)S(C)(O)O)C1=O YNNVOQCBZUOIPW-UHFFFAOYSA-N 0.000 description 2
- MXLVILISZWWNSX-UHFFFAOYSA-N CCS(Nc(c1c2nccc1)c(C)c(C(NCc(cc1)ccc1F)=O)c2O)=O Chemical compound CCS(Nc(c1c2nccc1)c(C)c(C(NCc(cc1)ccc1F)=O)c2O)=O MXLVILISZWWNSX-UHFFFAOYSA-N 0.000 description 2
- NQCBCRXHOCMCCU-UHFFFAOYSA-N CCS(Nc(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)=O Chemical compound CCS(Nc(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)=O NQCBCRXHOCMCCU-UHFFFAOYSA-N 0.000 description 2
- GFZURDASKGYTTM-UHFFFAOYSA-N CN(C(N)=O)c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O Chemical compound CN(C(N)=O)c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O GFZURDASKGYTTM-UHFFFAOYSA-N 0.000 description 2
- WIPVPXGGNCEHGO-UHFFFAOYSA-N CN(C)CCN(c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)S(C)(=O)=O Chemical compound CN(C)CCN(c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)S(C)(=O)=O WIPVPXGGNCEHGO-UHFFFAOYSA-N 0.000 description 2
- XFPCOIDOSCDDGU-UHFFFAOYSA-N CN(C)CCN(c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)S(C)(=O)=O Chemical compound CN(C)CCN(c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)S(C)(=O)=O XFPCOIDOSCDDGU-UHFFFAOYSA-N 0.000 description 2
- QMZQJXRXPQGZRT-UHFFFAOYSA-N CN(Cc(ccc(F)c1)c1C(O)=O)S(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O Chemical compound CN(Cc(ccc(F)c1)c1C(O)=O)S(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O QMZQJXRXPQGZRT-UHFFFAOYSA-N 0.000 description 2
- FOQGOVHDEGIPTB-UHFFFAOYSA-N CN(c(c(CN1CCO)c2C1=O)c(cc(Cc(cc1)ccc1F)cn1)c1c2O)[S-](C)O Chemical compound CN(c(c(CN1CCO)c2C1=O)c(cc(Cc(cc1)ccc1F)cn1)c1c2O)[S-](C)O FOQGOVHDEGIPTB-UHFFFAOYSA-N 0.000 description 2
- DBKGTJIFHOWFBU-UHFFFAOYSA-N CN(c(c(CN1Cc(ccc(F)c2)c2NS(C)(O)=O)c2C1=O)c(cccn1)c1c2O)S(C)(=O)=O Chemical compound CN(c(c(CN1Cc(ccc(F)c2)c2NS(C)(O)=O)c2C1=O)c(cccn1)c1c2O)S(C)(=O)=O DBKGTJIFHOWFBU-UHFFFAOYSA-N 0.000 description 2
- ZOLOEVWUOKAWJZ-UHFFFAOYSA-O CN(c(c1c2[N-]CC(Cc(cc3)ccc3F)=C1)c(CN(CCOC)C1=O)c1c2O)[SH+](C)(O)O Chemical compound CN(c(c1c2[N-]CC(Cc(cc3)ccc3F)=C1)c(CN(CCOC)C1=O)c1c2O)[SH+](C)(O)O ZOLOEVWUOKAWJZ-UHFFFAOYSA-O 0.000 description 2
- SSDDYKOXLPMYNE-UHFFFAOYSA-N CN(c(c1c2ncc3c1C1[N]4(Cc(cc5)c(C=O)cc5F)C31)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)S4(=O)=O Chemical compound CN(c(c1c2ncc3c1C1[N]4(Cc(cc5)c(C=O)cc5F)C31)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)S4(=O)=O SSDDYKOXLPMYNE-UHFFFAOYSA-N 0.000 description 2
- CTTGAJHBKLNRHK-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CN(CC#C)C1O)c1c2O)S(C)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CN(CC#C)C1O)c1c2O)S(C)(=O)=O CTTGAJHBKLNRHK-UHFFFAOYSA-N 0.000 description 2
- MGSWQXAUNQFXDH-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CN(Cc(cc1)cc(C(F)(F)F)c1F)C1=O)c1c2O)S(C)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CN(Cc(cc1)cc(C(F)(F)F)c1F)C1=O)c1c2O)S(C)(=O)=O MGSWQXAUNQFXDH-UHFFFAOYSA-N 0.000 description 2
- TUMROHNXADPROT-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)S(CCl)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)S(CCl)(=O)=O TUMROHNXADPROT-UHFFFAOYSA-N 0.000 description 2
- SKLFDMNQOLZIHQ-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CN(Cc(ccc(F)c1)c1O)C1=O)c1c2O)S(C)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CN(Cc(ccc(F)c1)c1O)C1=O)c1c2O)S(C)(=O)=O SKLFDMNQOLZIHQ-UHFFFAOYSA-N 0.000 description 2
- ZZXUBSNSMZNXNX-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CN(Cc1ccc(C(F)(F)F)[o]1)C1=O)c1c2O)S=O Chemical compound CN(c(c1c2nccc1)c(CN(Cc1ccc(C(F)(F)F)[o]1)C1=O)c1c2O)S=O ZZXUBSNSMZNXNX-UHFFFAOYSA-N 0.000 description 2
- BGBIWQNDGLZBNW-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CN(Cc1ccc[o]1)C1=O)c1c2O)S(C)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CN(Cc1ccc[o]1)C1=O)c1c2O)S(C)(=O)=O BGBIWQNDGLZBNW-UHFFFAOYSA-N 0.000 description 2
- HSDFUNABDJGRTI-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)S(CCl)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)S(CCl)(=O)=O HSDFUNABDJGRTI-UHFFFAOYSA-N 0.000 description 2
- HBOYBPHFLIVGDH-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)S(NCc(c(C(OC)=O)c1)ccc1F)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)S(NCc(c(C(OC)=O)c1)ccc1F)(=O)=O HBOYBPHFLIVGDH-UHFFFAOYSA-N 0.000 description 2
- NLYWGJJTWWEQSU-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)S(c(cc1)ccc1Cl)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)S(c(cc1)ccc1Cl)(=O)=O NLYWGJJTWWEQSU-UHFFFAOYSA-N 0.000 description 2
- NYHBNBZPUJYZDI-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CNCc1ccc[O-]1)c(C=O)c2O)S(C)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CNCc1ccc[O-]1)c(C=O)c2O)S(C)(=O)=O NYHBNBZPUJYZDI-UHFFFAOYSA-N 0.000 description 2
- VUSPEPKNAGPQGT-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CNCc1cccc(Cl)c1O)c(C=O)c2O)S(C)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CNCc1cccc(Cl)c1O)c(C=O)c2O)S(C)(=O)=O VUSPEPKNAGPQGT-UHFFFAOYSA-N 0.000 description 2
- UOPHLZDCOFLDOZ-UHFFFAOYSA-N CN(c(c1c2nccc1)c(CNCc1n[s]c(Cl)n1)c(C=O)c2O)S(C)(=O)=O Chemical compound CN(c(c1c2nccc1)c(CNCc1n[s]c(Cl)n1)c(C=O)c2O)S(C)(=O)=O UOPHLZDCOFLDOZ-UHFFFAOYSA-N 0.000 description 2
- SULQPSWGZKUSRG-UHFFFAOYSA-N CN(c(c1cccnc11)c(CN(Cc2n[s]c(Cl)n2)C2=O)c2c1O)S(C)(=O)=O Chemical compound CN(c(c1cccnc11)c(CN(Cc2n[s]c(Cl)n2)C2=O)c2c1O)S(C)(=O)=O SULQPSWGZKUSRG-UHFFFAOYSA-N 0.000 description 2
- PKNDLGBIJALPKH-UHFFFAOYSA-N CN(c(ccc(F)c1)c1C(O)=O)S(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O Chemical compound CN(c(ccc(F)c1)c1C(O)=O)S(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O PKNDLGBIJALPKH-UHFFFAOYSA-N 0.000 description 2
- UIXJKXQGIWQVHI-UHFFFAOYSA-N CNCN(C(C=O)=C(c1c2cc(Cc(cc3)ccc3F)cn1)O)C2=O Chemical compound CNCN(C(C=O)=C(c1c2cc(Cc(cc3)ccc3F)cn1)O)C2=O UIXJKXQGIWQVHI-UHFFFAOYSA-N 0.000 description 2
- NTSPJSHMXVXPNV-UHFFFAOYSA-N CNCc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2OC Chemical compound CNCc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2OC NTSPJSHMXVXPNV-UHFFFAOYSA-N 0.000 description 2
- MTSJPVVMRSJFEZ-UHFFFAOYSA-N CNc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN(C)C1=O)c1c2O Chemical compound CNc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN(C)C1=O)c1c2O MTSJPVVMRSJFEZ-UHFFFAOYSA-N 0.000 description 2
- ABWYHRNMSJPVQV-UHFFFAOYSA-N CNc1c(CN(C)S(N(C)c(c2c3nccc2)c(CN(Cc(cc2)ccc2F)C2=O)c2c3O)(=O)=O)ccc(F)c1 Chemical compound CNc1c(CN(C)S(N(C)c(c2c3nccc2)c(CN(Cc(cc2)ccc2F)C2=O)c2c3O)(=O)=O)ccc(F)c1 ABWYHRNMSJPVQV-UHFFFAOYSA-N 0.000 description 2
- XOPDSRUMJACZDC-UHFFFAOYSA-O CNc1cc(F)ccc1N(C)S(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2[OH2+])(=O)=O Chemical compound CNc1cc(F)ccc1N(C)S(N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2[OH2+])(=O)=O XOPDSRUMJACZDC-UHFFFAOYSA-O 0.000 description 2
- XRDJLTPWNVZBRP-UHFFFAOYSA-N COCCN(Cc(c1c(c2ncc(Cc(cc3)ccc3F)cc22)O)c2OC)C1=O Chemical compound COCCN(Cc(c1c(c2ncc(Cc(cc3)ccc3F)cc22)O)c2OC)C1=O XRDJLTPWNVZBRP-UHFFFAOYSA-N 0.000 description 2
- KUIHFMIDVKIKNJ-UHFFFAOYSA-N COc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN(CCN1COCC1)C1=O)c1c2O Chemical compound COc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN(CCN1COCC1)C1=O)c1c2O KUIHFMIDVKIKNJ-UHFFFAOYSA-N 0.000 description 2
- YRCBMMOLLIWWFJ-UHFFFAOYSA-N COc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNCCN1COCC1)c(C=O)c2O Chemical compound COc(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNCCN1COCC1)c(C=O)c2O YRCBMMOLLIWWFJ-UHFFFAOYSA-N 0.000 description 2
- HSZKDOOCXPYNKV-UHFFFAOYSA-N COc(c1cc(Cc(cc2)ccc2F)cnc11)c(CN(CCO)C2=O)c2c1O Chemical compound COc(c1cc(Cc(cc2)ccc2F)cnc11)c(CN(CCO)C2=O)c2c1O HSZKDOOCXPYNKV-UHFFFAOYSA-N 0.000 description 2
- SQPYBIHYWXWQHI-UHFFFAOYSA-N CS(N(CC1CC1)c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)(=O)=O Chemical compound CS(N(CC1CC1)c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)(=O)=O SQPYBIHYWXWQHI-UHFFFAOYSA-N 0.000 description 2
- YVEFNZORMDZHQO-UHFFFAOYSA-N CS(N(CC1CC1)c(c1cccnc11)c(CN(Cc(cc2)ccc2F)C2=O)c2c1O)(=O)=O Chemical compound CS(N(CC1CC1)c(c1cccnc11)c(CN(Cc(cc2)ccc2F)C2=O)c2c1O)(=O)=O YVEFNZORMDZHQO-UHFFFAOYSA-N 0.000 description 2
- WNYMLEXEAKZUQM-UHFFFAOYSA-N CS(N(c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)S=O)=O Chemical compound CS(N(c(c1c2nccc1)c(CNCc(cc1)ccc1F)c(C=O)c2O)S=O)=O WNYMLEXEAKZUQM-UHFFFAOYSA-N 0.000 description 2
- IUELGPBYMHKDMZ-UHFFFAOYSA-N C[N-]c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN(C)C1=O)c1c2O Chemical compound C[N-]c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN(C)C1=O)c1c2O IUELGPBYMHKDMZ-UHFFFAOYSA-N 0.000 description 2
- WBNHBOHGJRCHNE-UHFFFAOYSA-O C[NH2+]c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNCCF)c(C=O)c2O Chemical compound C[NH2+]c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CNCCF)c(C=O)c2O WBNHBOHGJRCHNE-UHFFFAOYSA-O 0.000 description 2
- UJKROLBKYLEGAB-UHFFFAOYSA-N C[S-](N(c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)SO)O Chemical compound C[S-](N(c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)SO)O UJKROLBKYLEGAB-UHFFFAOYSA-N 0.000 description 2
- SBOXXELGGFQIKW-UHFFFAOYSA-N Cc(c(C(NCc(ccc(F)c1)c1NS(C)(=O)=O)=O)c(c1ncccc11)O)c1N(C)S(C)(=O)=O Chemical compound Cc(c(C(NCc(ccc(F)c1)c1NS(C)(=O)=O)=O)c(c1ncccc11)O)c1N(C)S(C)(=O)=O SBOXXELGGFQIKW-UHFFFAOYSA-N 0.000 description 2
- BCSLLTBVZWIXJR-UHFFFAOYSA-N Cc(c(C=O)c(c1c2c([O]=S(C)=O)c(Cc(cc3)ccc3F)cn1)O)c2[N-]C Chemical compound Cc(c(C=O)c(c1c2c([O]=S(C)=O)c(Cc(cc3)ccc3F)cn1)O)c2[N-]C BCSLLTBVZWIXJR-UHFFFAOYSA-N 0.000 description 2
- ZLWNMRAWERUZPN-UHFFFAOYSA-N Cc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2N(C)S Chemical compound Cc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2N(C)S ZLWNMRAWERUZPN-UHFFFAOYSA-N 0.000 description 2
- YNIRDNASTFRJHO-UHFFFAOYSA-O Cc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2N[SH+](C)(O)O Chemical compound Cc(c(C=O)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2N[SH+](C)(O)O YNIRDNASTFRJHO-UHFFFAOYSA-O 0.000 description 2
- YESIBFWNWSGNMB-UHFFFAOYSA-N Cc(cc1)ccc1[S+](N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O Chemical compound Cc(cc1)ccc1[S+](N(C)c(c1c2nccc1)c(CN(Cc(cc1)ccc1F)C1=O)c1c2O)(=O)=O YESIBFWNWSGNMB-UHFFFAOYSA-N 0.000 description 2
- OMRXMTMJPWDULI-UHFFFAOYSA-N Cc(ccnc12)c1c(O)c(C=O)c(C(NCc(cc1)ccc1F)=O)c2O Chemical compound Cc(ccnc12)c1c(O)c(C=O)c(C(NCc(cc1)ccc1F)=O)c2O OMRXMTMJPWDULI-UHFFFAOYSA-N 0.000 description 2
- HIEKVVIHFHQVMX-UHFFFAOYSA-N Cc1ccnc(c(O)c2C(N3Cc(cc4)ccc4F)=O)c1c(O)c2C3=O Chemical compound Cc1ccnc(c(O)c2C(N3Cc(cc4)ccc4F)=O)c1c(O)c2C3=O HIEKVVIHFHQVMX-UHFFFAOYSA-N 0.000 description 2
- MYKIYNJKKSQPMW-SXWUCCAISA-N Nc(c1c2ncc(Br)c1)c(C(C[C@H](CCCc(cc1)ccc1F)C1O)=O)c1c2O Chemical compound Nc(c1c2ncc(Br)c1)c(C(C[C@H](CCCc(cc1)ccc1F)C1O)=O)c1c2O MYKIYNJKKSQPMW-SXWUCCAISA-N 0.000 description 2
- JINCWQVIPBCFLP-UHFFFAOYSA-N OC(C1N2CCN(Cc(cc3)ccc3F)C1=O)=C1N=CC=CC1S2(=O)=O Chemical compound OC(C1N2CCN(Cc(cc3)ccc3F)C1=O)=C1N=CC=CC1S2(=O)=O JINCWQVIPBCFLP-UHFFFAOYSA-N 0.000 description 2
- HQFMDRUZDJXKPO-UHFFFAOYSA-N OC(c1c2cccn1)=C(C(N(Cc(cc1)ccc1F)C1)=O)N1C2=O Chemical compound OC(c1c2cccn1)=C(C(N(Cc(cc1)ccc1F)C1)=O)N1C2=O HQFMDRUZDJXKPO-UHFFFAOYSA-N 0.000 description 2
- VNOUKGBAJLBKTR-UHFFFAOYSA-M Oc(c1c(c(O)c2C(N3Cc(cc4)ccc4F)=O)[N-]CC(Cc(cc4)ccc4F)=C1)c2C3=O Chemical compound Oc(c1c(c(O)c2C(N3Cc(cc4)ccc4F)=O)[N-]CC(Cc(cc4)ccc4F)=C1)c2C3=O VNOUKGBAJLBKTR-UHFFFAOYSA-M 0.000 description 2
- ADWWFLNIPKMMNG-UHFFFAOYSA-O Oc(c1c(c(O)c2C(N3Cc(cc4)ccc4[FH+])=O)ncc(Cc(cc4)ccc4F)c1)c2C3=O Chemical compound Oc(c1c(c(O)c2C(N3Cc(cc4)ccc4[FH+])=O)ncc(Cc(cc4)ccc4F)c1)c2C3=O ADWWFLNIPKMMNG-UHFFFAOYSA-O 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- ZMSIFDIKIXVLDF-UHFFFAOYSA-N 2-methyl-1,3,4-oxadiazole Chemical compound CC1=NN=CO1 ZMSIFDIKIXVLDF-UHFFFAOYSA-N 0.000 description 1
- HPMAPRIRJMGMMI-NDJUKFIMSA-N C/C=C(/Cc1cc(c(N(C)S(C)(=O)=O)c(CN(CCO)C2=O)c2c2O)c2nc1)\C=C/CF Chemical compound C/C=C(/Cc1cc(c(N(C)S(C)(=O)=O)c(CN(CCO)C2=O)c2c2O)c2nc1)\C=C/CF HPMAPRIRJMGMMI-NDJUKFIMSA-N 0.000 description 1
- KONVRDORKRYYEQ-UHFFFAOYSA-N CC#CCN(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)CC1=O Chemical compound CC#CCN(Cc(c1c(c2c3cccn2)O)c3N(C)S(C)(=O)=O)CC1=O KONVRDORKRYYEQ-UHFFFAOYSA-N 0.000 description 1
- LCPFKXMZAAVQNU-UHFFFAOYSA-O CCN(Cc(c1c(c2c3cc(Cc(cc4)ccc4F)cn2)O)c3N(C)[S+](C)(O)=O)C1=O Chemical compound CCN(Cc(c1c(c2c3cc(Cc(cc4)ccc4F)cn2)O)c3N(C)[S+](C)(O)=O)C1=O LCPFKXMZAAVQNU-UHFFFAOYSA-O 0.000 description 1
- SXPZREPAZIGUET-UHFFFAOYSA-O CCN(Cc(c1c(c2ncc(Cc(cc3)ccc3F)cc22)O)c2[OH+]C)C1O Chemical compound CCN(Cc(c1c(c2ncc(Cc(cc3)ccc3F)cc22)O)c2[OH+]C)C1O SXPZREPAZIGUET-UHFFFAOYSA-O 0.000 description 1
- JXLVCCHVFVAIPL-UHFFFAOYSA-O CCN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(C)c(C1OC1)c2O)[S+](C)(O)=O Chemical compound CCN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(C)c(C1OC1)c2O)[S+](C)(O)=O JXLVCCHVFVAIPL-UHFFFAOYSA-O 0.000 description 1
- GFDIOSFYUDYNIA-UHFFFAOYSA-N CN(Cc(c1c(c2c3cc(Cc(cc4)ccc4F)cn2)O)c3OC)C1=O Chemical compound CN(Cc(c1c(c2c3cc(Cc(cc4)ccc4F)cn2)O)c3OC)C1=O GFDIOSFYUDYNIA-UHFFFAOYSA-N 0.000 description 1
- ACGUPURFNDYXDD-UHFFFAOYSA-N CN(c(c(CN1C)c2C1=O)c(cc(Cc(cc1)ccc1F)cn1)c1c2O)S(C)(=O)=O Chemical compound CN(c(c(CN1C)c2C1=O)c(cc(Cc(cc1)ccc1F)cn1)c1c2O)S(C)(=O)=O ACGUPURFNDYXDD-UHFFFAOYSA-N 0.000 description 1
- DJGNNXAMEKFIEB-UHFFFAOYSA-O CN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN(CCOC)C1=O)c1c2O)[S+](C)(O)=O Chemical compound CN(c(c1c2ncc(Cc(cc3)ccc3F)c1)c(CN(CCOC)C1=O)c1c2O)[S+](C)(O)=O DJGNNXAMEKFIEB-UHFFFAOYSA-O 0.000 description 1
- SQSUTXNQWMZOGR-UHFFFAOYSA-N COCCNCc(c(C=O)c(c1ncc(Cc(cc2)ccc2F)cc11)O)c1OC Chemical compound COCCNCc(c(C=O)c(c1ncc(Cc(cc2)ccc2F)cc11)O)c1OC SQSUTXNQWMZOGR-UHFFFAOYSA-N 0.000 description 1
- MIOGGOQFWKNVAZ-UHFFFAOYSA-N COc(c(CN1CCN2CCOCC2)c2C1=O)c(cc(Cc(cc1)ccc1F)cn1)c1c2O Chemical compound COc(c(CN1CCN2CCOCC2)c2C1=O)c(cc(Cc(cc1)ccc1F)cn1)c1c2O MIOGGOQFWKNVAZ-UHFFFAOYSA-N 0.000 description 1
- ZXAYTCVYVKCPNJ-UHFFFAOYSA-N Cc(c(C)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2NS(C)(C)(O)=O Chemical compound Cc(c(C)c(c1c2cc(Cc(cc3)ccc3F)cn1)O)c2NS(C)(C)(O)=O ZXAYTCVYVKCPNJ-UHFFFAOYSA-N 0.000 description 1
- MNJCWXRCNVOCAB-UHFFFAOYSA-N Cc(c(CON)c(c1ncc(Cc(cc2)ccc2F)cc11)O)c1N(C)[S](C)(=C)(=O)=O Chemical compound Cc(c(CON)c(c1ncc(Cc(cc2)ccc2F)cc11)O)c1N(C)[S](C)(=C)(=O)=O MNJCWXRCNVOCAB-UHFFFAOYSA-N 0.000 description 1
- VKEQBMCRQDSRET-UHFFFAOYSA-N Methylone Chemical compound CNC(C)C(=O)C1=CC=C2OCOC2=C1 VKEQBMCRQDSRET-UHFFFAOYSA-N 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80102006P | 2006-05-16 | 2006-05-16 | |
| PCT/US2007/011851 WO2007136714A2 (en) | 2006-05-16 | 2007-05-16 | Integrase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009537546A JP2009537546A (ja) | 2009-10-29 |
| JP2009537546A5 true JP2009537546A5 (enExample) | 2011-06-16 |
Family
ID=38573219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511069A Pending JP2009537546A (ja) | 2006-05-16 | 2007-05-16 | インテグラーゼ阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20090306054A1 (enExample) |
| EP (1) | EP2066670A2 (enExample) |
| JP (1) | JP2009537546A (enExample) |
| AU (1) | AU2007254190A1 (enExample) |
| CA (1) | CA2651579A1 (enExample) |
| NZ (1) | NZ572367A (enExample) |
| WO (1) | WO2007136714A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090291921A1 (en) * | 2007-11-20 | 2009-11-26 | Gilead Sciences, Inc. | Integrase inhibitors |
| US20100233270A1 (en) | 2009-01-08 | 2010-09-16 | Northwestern University | Delivery of Oligonucleotide-Functionalized Nanoparticles |
| US9018227B2 (en) | 2010-03-19 | 2015-04-28 | Indiana State University | Nicotinic acetylcholine receptor agonists |
| WO2012131539A1 (en) | 2011-03-31 | 2012-10-04 | Pfizer Inc. | Novel bicyclic pyridinones |
| US9089574B2 (en) | 2011-11-30 | 2015-07-28 | Emory University | Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections |
| UA110688C2 (uk) | 2012-09-21 | 2016-01-25 | Пфайзер Інк. | Біциклічні піридинони |
| KR102000382B1 (ko) | 2015-02-03 | 2019-07-15 | 화이자 인코포레이티드 | 신규 시클로프로파벤조푸라닐 피리도피라진디온 |
| CN106632397B (zh) * | 2016-12-01 | 2019-03-22 | 齐鲁天和惠世制药有限公司 | 一种6α-溴青霉烷-3α-羧酸二苯甲酯-1β-氧化物的制备方法 |
| AR111295A1 (es) | 2017-03-20 | 2019-06-26 | Forma Therapeutics Inc | Composiciones de pirrolopirrol como activadores de piruvato quinasa (pkr) |
| WO2020061255A1 (en) | 2018-09-19 | 2020-03-26 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
| US20200129485A1 (en) | 2018-09-19 | 2020-04-30 | Forma Therapeutics, Inc. | Treating sickle cell disease with a pyruvate kinase r activating compound |
| CN112142714A (zh) * | 2019-06-27 | 2020-12-29 | 山东润博生物科技有限公司 | 一种灭草烟的合成方法 |
| CN112142712A (zh) * | 2019-06-27 | 2020-12-29 | 山东润博生物科技有限公司 | 一种甲基咪草烟的合成方法 |
| CN112142713A (zh) * | 2019-06-27 | 2020-12-29 | 山东润博生物科技有限公司 | 一种咪草烟的合成方法 |
| MX2022003025A (es) | 2019-09-19 | 2022-04-07 | Forma Therapeutics Inc | Activacion de la piruvato cinasa r. |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
| CN116675684B (zh) * | 2023-08-02 | 2023-11-07 | 上海翰森生物医药科技有限公司 | 含炔基稠环类衍生物拮抗剂、其制备方法和应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816570A (en) * | 1982-11-30 | 1989-03-28 | The Board Of Regents Of The University Of Texas System | Biologically reversible phosphate and phosphonate protective groups |
| US4968788A (en) | 1986-04-04 | 1990-11-06 | Board Of Regents, The University Of Texas System | Biologically reversible phosphate and phosphonate protective gruops |
| ES2083580T3 (es) | 1990-06-13 | 1996-04-16 | Arnold Glazier | Profarmacos de fosforo. |
| DK0481214T3 (da) * | 1990-09-14 | 1999-02-22 | Acad Of Science Czech Republic | Prolægemidler af phosphonater |
| US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
| US5683999A (en) * | 1995-03-17 | 1997-11-04 | The Dupont Merck Pharmaceutical Company | Cyclic urea HIV protease inhibitors |
| US6312662B1 (en) | 1998-03-06 | 2001-11-06 | Metabasis Therapeutics, Inc. | Prodrugs phosphorus-containing compounds |
| AU4225499A (en) | 1998-06-03 | 1999-12-20 | Merck & Co., Inc. | Hiv integrase inhibitors |
| WO1999062513A1 (en) | 1998-06-03 | 1999-12-09 | Merck & Co., Inc. | Hiv integrase inhibitors |
| WO2000036132A1 (en) | 1998-12-14 | 2000-06-22 | Merck & Co., Inc. | Hiv integrase inhibitors |
| BR9916583A (pt) | 1998-12-25 | 2001-09-25 | Shionogi & Co | Derivados heteroaromáticos tendo uma atividade inibitória contra integrase de hiv |
| EP1186599A4 (en) * | 1999-06-02 | 2003-02-26 | Shionogi & Co | NOVEL PROCESS FOR THE PREPARATION OF SUBSTITUTED PROPENONE DERIVATIVES |
| WO2001000578A1 (en) | 1999-06-25 | 2001-01-04 | Merck & Co., Inc. | 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| US6245806B1 (en) | 1999-08-03 | 2001-06-12 | Merck & Co., Inc. | HIV integrase inhibitors |
| AU8009900A (en) | 1999-10-13 | 2001-04-23 | Merck & Co., Inc. | Hiv integrase inhibitors |
| AU2002230392A1 (en) | 2000-10-12 | 2002-05-15 | Merck & Co., Inc. | AZA-and polyaza-naphthalenyl ketones useful as HIV integrase inhibitors |
| EP1326865B1 (en) | 2000-10-12 | 2009-05-06 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| JP2004517860A (ja) | 2000-10-12 | 2004-06-17 | メルク エンド カムパニー インコーポレーテッド | Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類 |
| AU1532802A (en) | 2000-10-12 | 2002-04-22 | Merck & Co Inc | Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
| ATE404537T1 (de) * | 2002-08-13 | 2008-08-15 | Shionogi & Co | Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung |
| AU2003301439A1 (en) | 2002-10-16 | 2004-05-04 | Gilead Sciences, Inc. | Pre-organized tricyclic integrase inhibitor compounds |
| CN1812992A (zh) | 2003-04-28 | 2006-08-02 | 泰博特克药品有限公司 | Hiv整合酶抑制剂 |
| TW200510425A (en) * | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
| US7919623B2 (en) | 2004-02-04 | 2011-04-05 | Shionogi & Co., Ltd. | Naphthyridine derivatives having inhibitory activity against HIV integrase |
| SI1742642T1 (sl) | 2004-04-14 | 2009-04-30 | Gilead Sciences Inc | Fosfonatni analogi inhibitorskih spojin HIV integraze |
| US20070072831A1 (en) | 2005-05-16 | 2007-03-29 | Gilead Sciences, Inc. | Integrase inhibitor compounds |
| EP1973908A2 (en) | 2005-12-21 | 2008-10-01 | Gilead Sciences, Inc. | Processes and intermediates useful for preparing integrase inhibitor compounds |
-
2007
- 2007-05-16 WO PCT/US2007/011851 patent/WO2007136714A2/en not_active Ceased
- 2007-05-16 US US12/299,885 patent/US20090306054A1/en not_active Abandoned
- 2007-05-16 JP JP2009511069A patent/JP2009537546A/ja active Pending
- 2007-05-16 EP EP07794999A patent/EP2066670A2/en not_active Withdrawn
- 2007-05-16 NZ NZ572367A patent/NZ572367A/en not_active IP Right Cessation
- 2007-05-16 US US11/804,041 patent/US8008287B2/en not_active Expired - Fee Related
- 2007-05-16 AU AU2007254190A patent/AU2007254190A1/en not_active Abandoned
- 2007-05-16 CA CA002651579A patent/CA2651579A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7113009B2 (ja) | 置換ピリジノン含有三環式化合物およびそれを使用する方法 | |
| ES2670864T3 (es) | Inhibidores de histonas desmetilasas | |
| AU2014219283C1 (en) | Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders | |
| CA2505033C (en) | Non-nucleoside reverse transcriptase inhibitors | |
| JP2005501796A5 (enExample) | ||
| CN101340947B (zh) | Iap-抑制剂和紫杉烷7的组合 | |
| JP2021535112A5 (enExample) | ||
| CA3093851A1 (en) | Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same | |
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| JP6021805B2 (ja) | 腫瘍治療剤 | |
| RU2013143028A (ru) | Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ | |
| TW200301698A (en) | Acridone inhibitors of IMPDH enzyme | |
| CA2606783A1 (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
| JP2009543867A5 (enExample) | ||
| RU2005120780A (ru) | Соединения с конденсированным 1,3-дигидроимидазольным циклом | |
| JP2008543886A5 (enExample) | ||
| JP6795518B2 (ja) | キナーゼを阻害する組成物及び方法 | |
| JP5465233B2 (ja) | 置換ピラゾールアミドおよびその使用 | |
| JP2023544716A5 (enExample) | ||
| JP2022511477A5 (enExample) | ||
| JP2021523108A5 (enExample) | ||
| JP2005527521A5 (enExample) | ||
| JP2016525104A5 (enExample) | ||
| RU2007122485A (ru) | Ингибиторы киназы | |
| JP2021522270A5 (enExample) |